LLY vs ABBV — Key Metrics
| Metric | LLY (ELI LILLY & CO) | ABBV (ABBVIE INC) |
|---|---|---|
| Price | 1157.08 | 261.59 |
| Market Cap | 1.09 Trillion | 462.26 Billion |
| P/E (TTM) | 38.78 | 73.69 |
| P/B (Quarterly) | 32.506 | -72.404 |
| P/S (TTM) | 13.67 | 7.18 |
| Net Profit Margin (TTM) | 33.5 | 9.8 |
| Gross Margin (TTM) | 83.4 | 71.5 |
| ROE (TTM) | 92.6 | -135.7 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
LLY · ELI LILLY & CO
Underperform
ABBV · ABBVIE INC
Outperform
Recommendation Summary
Stock LLY is projected to underperform the market, stock ABBV is projected to outperform the market. Upfront Recommendation: ABBV.
Financial Metrics
Prices delayed ~15 min
| LLY | Metrics | ABBV |
|---|---|---|
| $1,157.08 | Price | $261.59 |
| — | Market Capitalization | — |
| 38.78 | Price to Earnings Ratio | 73.69 |
| 13.67 | Price to Sales | 7.18 |
| 59.88 | Price to FCF Ratio | 25.38 |
| 16.39 | Price to Gross Profit | 10.04 |
| 74.62 | Price to R&D | 47.59 |
| 16.84 | Price to Current Assets | 13.73 |